Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: April 05 2020 2:36 am
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
Notice of Special Interest (NOSI): Competitive Supplements/Revisions (R01) Available for INCLUDE (Investigation of Co-occurring Conditions across the NOT-OD-20-023 NIH Dec 18 2019 N/A Notice Special Interest NOSI): Competitive Supplements/Revisions R01) Available INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Competitive Supplement/Revision Clinical Trial Optional) Notice Number: NOT-OD-20-023 Key Dates Release Date: December 18, 2019 First Available Due Date: March 05, 2020 Expiration Date: September 08, 2022 Related Announcements NOT-OD-20-022 NOT-OD-20-012 Notice Intent Publish Funding Opportunity Announcements Fiscal Year 2020 the INCLUDE INvestigation Co-occurring conditions across Lifespan Understand Down syndromE) Project PA-19-055 Research Project Grant Parent R01 Clinical Trial Required) PA-19-056 NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-091 NIH Research Project Grant Parent R01 Basic Experimental Studies Humans Required) NOT-OD-20-017 Notice Special Interest Encourage Development Animal Models Related Biological Materials Research Related Down Syndrome NOT-OD-20-020 Notice Special Interest NOSI): Ruth L. Kirschstein National Research Service Award NRSA) Fellowship Awards Support Training Research Related Down Syndrome Part the INCLUDE Project NOT-OD-20-021 Notice Special Interest NOSI): Mentored Career Development Awards Support Training Research Related Down Syndrome Part the INCLUDE Project NOT-OD-20-022 Notice Special Interest: Administrative Supplements the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project NIH-funded K12 KL2 Institutional Career Development Awards NOT-OD-20-023 Notice Special Interest: Availability Competitive Supplements/Revisions the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Competitive Supplement/Revision Clinical Trial Optional) NOT-OD-20-024 Notice Special Interest: Availability Administrative Supplements the INCLUDE INvestigation Co-occurring conditions across Lifespan Understand Down syndromE) Project NOT-OD-20-025 Notice Special Interest: NIH Research Project Grants Down Syndrome R01) RFA-OD-20-003 Clinical Trials Development Co-Occurring Conditions Individuals Down syndrome: Phased Awards INCLUDE R61/R33 Clinical Trial Required) RFA-OD-20-004 INvestigation Co-occurring conditions across Lifespan Understand Down syndromE INCLUDE) Clinical Trial Readiness R21 Clinical Trial Allowed) RFA-OD-20-005 Transformative Research Award the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project R01 Clinical Trial Allowed) RFA-OD-20-006 Small Research Grants Analyses Down Syndrome-related Research Data the INCLUDE Project R03 Clinical Trial Allowed) RFA-OD-20-007 Development the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Data Coordinating Center U2C) Issued Office The Director, National Institutes Health OD) National Heart, Lung, Blood Institute NHLBI) National Institute Aging NIA) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Minority Health Health Disparities NIMHD) National Cancer Institute NCI) Purpose Background INvestigation Co-occurring conditions across Lifespan Understand Down syndromE INCLUDE) Project developed response Fiscal Year 2018 2019 Omnibus Appropriations Reports, encouraged NIH expand current efforts Down syndrome DS) common co-occurring conditions also seen the general population while increasing pipeline DS investigators. Information projects were funded in 2018 2019, well the INCLUDE Project Research Plan, available the INCLUDE Project website. Individuals Down syndrome DS) face significant changing health challenges have often excluded participation research could improve health outcomes quality life. population understudied even though DS the most common genetic cause intellectual developmental disabilities IDD) and, the past 25 years, average lifespan doubled 30 60 years. addition intellectual disability, DS associated an increased prevalence autism epilepsy. 75% individuals DS experience cognitive decline a syndrome resembles Alzheimer’s disease, with onset decade two earlier typical Alzheimer’s disease. Individuals DS also high rates hearing loss, eye abnormalities, congenital heart defects, sleep apnea, pulmonary hypertension, gastrointestinal malformations, thyroid disease, leukemia, other autoimmune immune dysregulation disorders including celiac disease. However, people DS infrequently develop solid tumors such breast prostate cancer. Despite multiple risk factors coronary artery disease high rates obesity, sleep apnea, type 1 diabetes, people DS rarely develop atherosclerosis have myocardial infarctions. Understanding unique combination risk resiliencies inform medical advances individuals DS for individuals do have DS who share co-occurring conditions. Research Objectives Notice Special Interest NOSI) announces availability competitive revision formerly known competitive supplement) applications grantees active Research Project Grants R01) wish either expand scope their grant project focused DS to expand scope a non-DS grant incorporate DS-related research. Sharing resources effective communication outputs the broader communities a high priority the INCLUDE Project. Applicants responding this NOSI strongly encouraged describe plans rapid sharing data results well innovative data analytics approaches Goal 3, NIH Strategic Plan Data Science). list of Funding Priorities Institute Center is available the INCLUDE website. Applications response this NOSI should aligned the overall INCLUDE Project Research Plan, consists three components: Component 1: Targeted, high risk-high reward, basic science studies areas highly relevant Down syndrome Component 2: Cohort Study connect existing resources expand inclusion individuals Down syndrome Component 3: Inclusive clinical trials research co-occurring conditions individuals Down syndrome Projects propose recruit subjects Down syndrome encouraged promote enrollment research subjects the Down syndrome patient registry supported NIH, DS-Connect®. other data biospecimens human genetic non-genetic studies, awardees encouraged use biorepositories designated INCLUDE staff meet requirements broad sharing. NIH resource describing Common Data Elements may helpful during planning phases a project considering ways optimize data collection order facilitate broad data sharing. further information INCLUDE priorities, resource sharing expectations, participating NIH Institutes Centers, see Frequently Asked Questions. Application Submission Information Notice applies due dates or after March 5, 2020 subsequent receipt dates through September 7, 2022. Applications this initiative must submitted using of following funding opportunity announcements FOAs) their reissued equivalents. Although all NIH components indicated above listed Participating Organizations all FOAs listed below, applications this initiative be accepted the participating Institutes Centers NIH. PA-19-055 - NIH Research Project Grant Parent R01 Clinical Trial Required) PA-19-056 - NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-091 – NIH Research Project Grant Parent R01 Basic Experimental Studies Humans Required) instructions the SF424 R&R) Application Guide and funding opportunity announcement used submission must followed, the following additions: funding consideration, applicants must include NOT-OD-20-023 in Agency Routing Identifier field box 4b) the SF424 R&R form. Applications without information box 4b not considered this initiative. Revision applications must submitted the same project director/principal investigator PD/PI), Contact PD/PI multi-PI grants, listed the current award. Select Revision” option Box 8 the SF424 R&R form indicate TYPE APPLICATION, option Increase Award”. the Project Summary/Abstract field provide succinct accurate description the work proposed for revision. not the abstract the parent grant. Applicants must the same budget format i.e. R&R Budget Form PHS 398 Modular Budget Form) the current award. the Introduction Application field the PHS 398 Research Plan form attach one-page Introduction describes nature the revision how will influence specific aims, research design, methods the current grant. body the application should contain sufficient information the original grant application allow evaluation the proposed revision relation the goals the original application. Any budgetary changes the remainder the project period the current grant should discussed the Budget Justification. Revisions not extend beyond term the current award period. Grants their final year the project period the time application receipt not eligible under Notice. Applications nonresponsive terms this NOSI be be considered the NOSI initiative. Inquiries Please direct inquiries the contacts Section VII the listed funding opportunity announcements the following additions/substitutions: Scientific/Research Contact(s) list of contacts each participating NIH Institute Center available the INCLUDE website.    
Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2 Institutional Career Development Awards as part of the INCLUDE NOT-OD-20-022 NIH Dec 20 2019 N/A Notice Special Interest NOSI): Administrative Supplements NCATS CTSA Program KL2 Institutional Career Development Awards part the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project Notice Number: NOT-OD-20-022 Key Dates Release Date: December 19, 2019 First Available Due Date: March 02, 2020 Expiration Date: March 03, 2020 Related Announcements NOT-OD-20-012 Notice Intent Publish Funding Opportunity Announcements Fiscal Year 2020 the INCLUDE INvestigation Co-occurring conditions across Lifespan Understand Down syndromE) Project PA-18-591 Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) NOT-OD-20-017 Notice Special Interest Encourage Development Animal Models Related Biological Materials Research Related Down Syndrome NOT-OD-20-020 Notice Special Interest NOSI): Ruth L. Kirschstein National Research Service Award NRSA) Fellowship Awards Support Training Research Related Down Syndrome Part the INCLUDE Project NOT-OD-20-021 Notice Special Interest NOSI): Mentored Career Development Awards Support Training Research Related Down Syndrome Part the INCLUDE Project NOT-OD-20-022 Notice Special Interest: Administrative Supplements the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project NIH-funded K12 KL2 Institutional Career Development Awards NOT-OD-20-023 Notice Special Interest: Availability Competitive Supplements/Revisions the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Competitive Supplement/Revision Clinical Trial Optional) NOT-OD-20-024 Notice Special Interest: Availability Administrative Supplements the INCLUDE INvestigation Co-occurring conditions across Lifespan Understand Down syndromE) Project NOT-OD-20-025 Notice Special Interest: NIH Research Project Grants Down Syndrome R01) RFA-OD-20-003 Clinical Trials Development Co-Occurring Conditions Individuals Down syndrome: Phased Awards INCLUDE R61/R33 Clinical Trial Required) RFA-OD-20-004 INvestigation Co-occurring conditions across Lifespan Understand Down syndromE INCLUDE) Clinical Trial Readiness R21 Clinical Trial Allowed) RFA-OD-20-005 Transformative Research Award the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project R01 Clinical Trial Allowed) RFA-OD-20-006 Small Research Grants Analyses Down Syndrome-related Research Data the INCLUDE Project R03 Clinical Trial Allowed) RFA-OD-20-007 Development the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Data Coordinating Center U2C) Issued Office The Director, National Institutes Health OD) National Center Advancing Translational Sciences NCATS) Purpose Background INvestigation Co-occurring conditions across Lifespan Understand Down syndromE INCLUDE) Project developed response Fiscal Year 2018 2019 Omnibus Appropriations Reports, encouraged NIH expand current efforts Down syndrome DS) common co-occurring conditions also seen the general population while increasing pipeline DS investigators. Information projects were funded in 2018 2019, well the INCLUDE Project Research Plan, available the INCLUDE Project website. Individuals DS face significant changing health challenges have often excluded participation research could improve health outcomes quality life. population understudied even though DS the most common genetic cause intellectual developmental disabilities IDD) and, the past 25 years, average lifespan doubled 30 60 years. addition intellectual disability, DS associated an increased prevalence autism epilepsy. 75% individuals DS experience cognitive decline a syndrome resembles Alzheimer’s disease, with onset decade two earlier typical Alzheimer’s disease. Individuals DS also high rates hearing loss, eye abnormalities, congenital heart defects, sleep apnea, pulmonary hypertension, gastrointestinal malformations, thyroid disease, leukemia, other autoimmune immune dysregulation disorders including celiac disease. However, people DS infrequently develop solid tumors such breast prostate cancer. Despite multiple risk factors coronary artery disease high rates obesity, sleep apnea, type 1 diabetes, people DS rarely develop atherosclerosis have myocardial infarctions. Understanding unique combination risk resiliencies inform medical advances individuals DS for individuals do have DS who share co-occurring conditions. Research Objectives Notice Special Interest NOSI) announces NIH support the professional development early career scientists aiming establish career DS-related research. providing scientists career development research experiences , resources, mentorship, NIH intends foster pipeline investigators DS other intellectual disabilities will lead future research improve understanding the biology DS support development new treatments health conditions experienced those DS. Sharing resources effective communication outputs of appropriate interest to broader communities a high priority the INCLUDE Project. Applicants responding this NOSI are strongly encouraged describe plans rapid sharing data results well innovative data analytics approaches(see Goal 3, NIH Strategic Plan Data Science). NIH issuing NOSI expand community investigators conducting research related DS encouraging CTSAs recruit scientists physicians early their research careers develop research projects related co-occurring conditions associated DS. This NOSI support additional scholar slots those KL2 grants currently approved under CTSA Program. Sharing resources effective communication outputs the broader communities a high priority the INCLUDE Project. Applicants responding this NOSI strongly encouraged describe plans rapid sharing data results well innovative data analytics approaches Goal 3, NIH Strategic Plan Data Science). list of Funding Priorities Institute Center is available the INCLUDE website. Applications response this NOSI should aligned the overall INCLUDE Project Research Plan, consists three components: Component 1: Targeted, high risk-high reward, basic science studies areas highly relevant Down syndrome Component 2: Cohort Study connect existing resources expand inclusion individuals Down syndrome Component 3: Inclusive clinical trials research co-occurring conditions individuals Down syndrome Projects propose recruit subjects DS encouraged promote enrollment research subjects the Down syndrome patient registry supported NIH, DS-Connect®. other data biospecimens human genetic non-genetic studies, awardees encouraged use biorepositories designated INCLUDE staff meet requirements broad sharing. NIH resource describing Common Data Elements may helpful during planning phases a project considering ways optimize data collection order facilitate broad data sharing. further information INCLUDE priorities, resource sharing expectations, participating NIH Institutes Centers, see Frequently Asked Questions. Application Submission Information: Applications response this NOSI must submitted to PA-18-591 Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) its subsequent reissued equivalent. instructions the SF424 R&R) Application Guide and PA-18-591 must followed, the following additions: funding consideration, applicants must include NOT-OD-20-022 the Agency Routing Identifier field box 4b) the SF424 R&R form. Applications without information box 4b not considered this initiative. supplement must comply all the parent FOA requirements the KL2 program. Requests be a minimum two years a maximum four years consecutive funding each scholar, consisting 12-month appointments depending the eligibility the parent award). Scholar appointment(s) must able be fulfilled the active parent project period. Only existing awardees KL2 active awards eligible apply. process Streamlined Submissions using eRA Commons cannot used for PA-18-591 Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response to NOT-OD-20-022 in order facilitate efficient processing the request. Applicant organizations submit than application this NOSI. application should include only named candidate the supplement. unique project titles each application ensure our systems treat application a distinct submission. Application budgets must reflect actual needs the proposed project. Instructions Electronic Application Submission through Grants.gov: Use Apply” button(s) Part of the PA-18-591 program announcement access application forms package posted Grants.gov. presented more one form package, the form package Competition ID FORMS-E-ADMINSUPP-K12-KL2-KM1-D43". Prepare applications using SF424 R&R) forms associated the chosen package. Please note some forms marked optional the application package required submission applications this announcement. Follow instructions the SF424 R&R) Application Guide to ensure complete appropriate required optional forms, the following additional guidance: Program Plan: (may exceed 12 pages) Background: Include summary abstract the funded parent award project. Provide rationale the proposed supplement program its alignment the main goals the INCLUDE Project accelerate development new therapies, while simultaneously bringing promising agents already development individuals DS quickly possible). Research Program Plan: proposed plan should align the missions the INCLUDE Project the NCATS CTSA Program. Describe the proposed project contribute the scholar's career goals path independence. Present timeline career development activities potential publications grant applications future support. Career Development Plan: Describe key activities the candidate scholar during supplement, included mentored team science activities, didactic coursework including formal degree programs appropriate), other activities. Describe the proposed career development activities experiences enhance candidate's clinical translational science skills prepare for independent research career. Mentoring Faculty: Provide information the program faculty will involved the supplement activities, including complementary expertise experiences, active research other scholarly activities which faculty engaged, well experience mentoring individuals the proposed career stages. any co-mentor not located the sponsoring institution, describe frequency type communication will used engage scholar Vertebrate Animals: Complete section the scholar design conduct own independent vertebrate animal research. Approval the Institutional Animal Care Use Committee IACUC) the grantee institution required prior award. Letters Support: Attach appropriate letters all individuals confirming roles the proposed supplement program. Include signed letter, institutional letterhead, describes applicant institution’s commitment the planned proposed research project. letter should provide assurance the candidate scholar be able devote minimum 9 person-months 75 percent full-time professional effort) the supplement project. letter should confirm the scholar be supported the KL2 the supplement funded. letter should also identify laboratories, centers, other specialized institutional facilities will made available the scholar the research project. Project/Performance Site Location form: Include primary site where proposed supplement activities be performed. a portion the proposed supplement activities be performed any site(s), identify locations the fields provided. Senior/Key Person form: List PD/PI the first person regardless their role the supplement activities). List Senior/Key Personnel will serving members the scholar's mentoring team. List scholar proposed be added through supplement. Scholars this supplement support must an eRA Commons account, the scholar's Commons Username must entered the Credential field. Biographical sketch Senior/Key Personnel: Include biographical sketch the KL2 PD/PI(s) of of individuals will compose scholar's mentoring team. personal statement each individual will serve the scholar's mentoring team should include description his/her specific role mentoring scholar, the mentoring occur e.g., frequency mode), how scholar's progress be monitored during supplement award period. Biographical sketch Scholar: personal statement the scholar's biographical sketch should include description his/her research objectives career goals, why experience qualifications them particularly well-suited receive INCLUDE / NCATS CTSA Program KL2 supplement award. Relevant factors include previous training research accomplishments complementary integrative health research any source(s) current funding. Budget forms: Using R&R budget form, only include funds requested the additional supplement activities. R&R Project Information form, Facilities Other Resources attachment:Describe the scientific environment which career development activities be done contributes the probability the scholar's success e.g., institutional support, physical resources, intellectual rapport). CTSA Program hub Training Resources, describe training resources are available the scholar. PHS Human Subjects Clinical Trials Information form:Complete section the scholar design conduct own independent human subjects research. Approval the human subjects Institutional Review Board IRB) the grantee institution required prior award. Adherence the NIH policy including women minorities clinical studies must also ensured, additional human subjects’ involvement planned the supplement component.   Inquiries Please direct inquiries to: Erica Rosemond, Ph.D. National Center Advancing Translational Sciences NCATS) Telephone: 301-594-8927 Email: Erica.Rosemond@nih.gov
Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Li NOT-OD-20-024 NIH Dec 18 2019 N/A Notice Special Interest NOSI): Availability Administrative Supplements the INCLUDE INvestigation Co-occurring conditions across Lifespan Understand Down syndromE) Project Notice Number: NOT-OD-20-024 Key Dates Release Date: December 18, 2019 First Available Due Date: March 23, 2020 Expiration Date: March 24, 2022 Related Announcements NOT-OD-20-022 NOT-OD-20-012, Notice Intent Publish Funding Opportunity Announcements Fiscal Year 2020 the INCLUDE INvestigation Co-occurring conditions across Lifespan Understand Down syndromE) Project PA-18-591, Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) NOT-OD-20-017, Notice Special Interest Encourage Development Animal Models Related Biological Materials Research Related Down Syndrome NOT-OD-20-020 Notice Special Interest NOSI): Ruth L. Kirschstein National Research Service Award NRSA) Fellowship Awards Support Training Research Related Down Syndrome Part the INCLUDE Project NOT-OD-20-021 Notice Special Interest NOSI): Mentored Career Development Awards Support Training Research Related Down Syndrome Part the INCLUDE Project NOT-OD-20-022 Notice Special Interest: Administrative Supplements the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project NIH-funded K12 KL2 Institutional Career Development Awards NOT-OD-20-023 Notice Special Interest: Availability Competitive Supplements/Revisions the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Competitive Supplement/Revision Clinical Trial Optional) NOT-OD-20-025 Notice Special Interest: NIH Research Project Grants Down Syndrome R01) RFA-OD-20-003 Clinical Trials Development Co-Occurring Conditions Individuals Down syndrome: Phased Awards INCLUDE R61/R33 Clinical Trial Required) RFA-OD-20-004 INvestigation Co-occurring conditions across Lifespan Understand Down syndromE INCLUDE) Clinical Trial Readiness R21 Clinical Trial Allowed) RFA-OD-20-005 Transformative Research Award the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndrome) Project R01 Clinical Trial Allowed) RFA-OD-20-006 Small Research Grants Analyses Down Syndrome-related Research Data the INCLUDE Project R03 Clinical Trial Allowed) RFA-OD-20-007 Development the INCLUDE Investigation Co-occurring Conditions across Lifespan Understand Down syndromE) Project Data Coordinating Center U2C) Issued Office The Director, National Institutes Health OD) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Institute Aging NIA) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Environmental Health Sciences NIEHS) National Institute General Medical Sciences NIGMS) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) National Cancer Institute NCI) Purpose Office the Director the National Institutes Health NIH) announces opportunity investigators relevant active NIH-supported grants the participating Institutes listed above submit administrative supplement applications funded projects meet new NIH Down syndrome research objectives related the NIH INvestigation Co-occurring conditions across Lifespan Understand Down syndromE INCLUDE) Project. Notice soliciting administrative supplements the following mechanisms ONLY: R03, R21, R24, P01, P30, P40, P50, P51, U01, U10, U19, U24, U42, U54, UG1, UG3, UL1, U2C, K12, and T32. Background INCLUDE Project developed response Fiscal Year 2018 2019 Omnibus Appropriations Reports, encouraged NIH expand current efforts Down syndrome DS) common co-occurring conditions also seen the general population while increasing pipeline DS investigators. Information projects were funded 2018 2019, well the INCLUDE Project Research Plan, available the INCLUDE Project website. Individuals DS face significant changing health challenges have often excluded participation research could improve health outcomes quality life. population understudied even though DS the most common genetic cause intellectual developmental disabilities IDD) and, the past 25 years, average lifespan doubled 30 60 years. addition intellectual disability, DS associated an increased prevalence autism epilepsy. 75% individuals DS experience cognitive decline a syndrome resembles Alzheimer’s disease, with onset decade two earlier typical Alzheimer’s disease. Individuals DS also high rates hearing loss, eye abnormalities, congenital heart defects, sleep apnea, pulmonary hypertension, gastrointestinal malformations, thyroid disease, leukemia, other autoimmune immune dysregulation disorders including celiac disease. However, people DS infrequently develop solid tumors such breast prostate cancer. Despite multiple risk factors coronary artery disease high rates obesity, sleep apnea, type 1 diabetes, people DS rarely develop atherosclerosis have myocardial infarctions. Understanding unique combination risk resiliencies inform medical advances individuals DS for individuals do have DS who share co-occurring conditions. Research Objectives Notice Special Interest NOSI) announces NIH support the professional development early career scientists aiming establish career DS-related research. providing scientists training, resources, mentorship, NIH intends foster pipeline investigators DS other intellectual disabilities will lead future research improve understanding the biology DS support development new treatments health conditions experienced those DS. Sharing resources effective communication outputs the broader communities a high priority the INCLUDE Project. Applicants responding this NOSI strongly encouraged describe plans rapid sharing data results well innovative data analytics approaches Goal 3, NIH Strategic Plan Data Science). Supplement applications be eligible funding they address or of following components related the INCLUDE Project research objectives: Component 1: Targeted, high risk-high reward, basic science studies areas highly relevant Down syndrome Component 2: Cohort Study connect existing resources expand inclusion individuals Down Syndrome Component 3: Inclusive clinical trials research co-occurring conditions individuals Down syndrome Applications be considered eligible funding they: within scope the active parent award focused DS Propose address of three components listed above likely stimulate additional activity leading progress DS Address priority the IC issued parent award below more information) Supplements existing clinical trials allowed. proposed research must within scope the parent clinical trial the parent clinical trial award must two more budget years remaining the current project period. addition a new clinical trial was a part the parent award not allowed. Supplement requests addressing INCLUDE Components 2 3 should encourage participants DS their caregivers register in DS-Connect®: Down Syndrome Registry. INCLUDE website a list of Funding Priorities Institute Center , well list of contacts for participating NIH Institute Center. Before submitting supplement request, applicants strongly encouraged contact program officer the program contact the Institute Center IC) supporting parent award any questions to discuss whether proposed supplement within scope the parent award, focused the goals the INCLUDE Project consistent IC priorities. Award Project Period be eligible, parent award must active the current fiscal year i.e., parent award received funds the current fiscal year is in extension period), the research proposed the supplement should requested one year. awarding institute consider no-cost extension up an additional year the conclusion the first year. earliest anticipated start date August 2020, August 2021, August 2022. Budget Requests must reflect actual needs the proposed project. Supplement budget requests exceed 500,000 direct costs 50% the direct costs the current year the parent award exclusive Facilities Administrative costs sub-contracts) must receive permission the project officer IC Contact prior submission. Eligible Individuals Program Director/Principal Investigator) Individual(s) must hold active grant cooperative agreement. supplements parent awards include multiple PDs/PIs, supplement be requested any all the PDs/PIs accordance the existing leadership plan) submitted the awardee institution the parent award. Application Submission Information: Applications response this NOSI must submitted to PA-18-591 Administrative Supplements Existing NIH Grants Cooperative Agreements Parent Admin Supp Clinical Trial Optional) its subsequent reissued equivalent. instructions the SF424 R&R) Application Guide and PA-18-591 must followed, the following additions: order ensure identification, tracking, appropriate review their applications, applicants MUST follow special instructions: Application Due Date(s) – March 23, 2020, March 23, 2021, March 23, 2022 5:00 PM local time applicant organization. Applications must include NOT-OD-20-024 the Agency Routing Identifier field Box 4b) the SF424 R&R form. Applications without identifier NOT-OD-20-024) Box 4b not considered this initiative. process Streamlined Submissions using eRA Commons cannot used for PA-18-591. the form package the existing NIH Grants and/or Cooperative Agreements. Applicants strongly encouraged notify program contact the Institute supporting parent award a request been submitted response to NOT-OD-20-024 in order facilitate efficient processing the request. Applicant organizations submit than application this NOSI. unique project titles each application ensure our systems treat application a distinct submission. Application budgets must reflect actual needs the proposed project. Supplement budget requests exceed 500,000 direct costs 50% the direct costs the current year the parent award exclusive Facilities Administrative costs sub-contracts) must receive permission the project officer IC Contact prior submission. application Abstract section should describe proposed supplement, the Research Strategy section should include summary abstract the funded parent award project. Research Strategy should state relevance the parent award the INCLUDE project, articulate component(s) any IC-specific priorities the supplement addressing. Page Limits: NIH consider supplements a Research Strategy of no than 6 pages, addition the abstract. part the application investigators should submit abstract the proposed research shows relevance DS. Place abstract the Project Summary/Abstract section the SF424 R&R) Form. work include pilot projects resource development. Review Process: Each IC conduct administrative reviews applications their IC separately.   Inquiries Please direct inquiries to: Investigators planning submit application response this NOSI strongly encouraged contact discuss proposed research/aims a Program Officer the appropriate Institute Center listed this NOSI well advance the grant receipt date better determine appropriateness interest the awarding ICO. Please direct inquiries the contact the Institute, Center Office supporting parent award indicated the funding page the INCLUDE Project website.
Notice of Participation of the Office of Research Infrastructure Programs in PA-14-157 Early Stage Development of Technologies in Biomedical Computing NOT-OD-15-157 ORIP Sep 23 2015 N/A Notice Participation the Office Research Infrastructure Programs PA-14-157 Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R41/R42)" Notice Number: NOT-OD-15-157 Key Dates Release Date: September 23, 2015 Related Announcements PA-14-157     Issued Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Purpose purpose this Notice to inform potential applicants the Office Research Infrastructure Programs ORIP) participating, effective immediately, PA-14-157 quot;Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R41/R42)". following sections PA-14-157 been updated reflect ORIP participation this Funding Opportunity Announcement FOA.) Part 1.  Overview Information  Components Participating Organizations National Institute General Medical Sciences NIGMS) National Human Genome Research Institute NHGRI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Cancer Institute NCI) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Catalog Federal Domestic Assistance CFDA) Number(s) 93.859; 93.273; 93.361; 97.853; 93.286; 93.865; 93.846; 93.172; 93.113; 93.242; 93.879; 93.855; 93.856; 93.279; 93.393; 93.394; 93.395; 93.396; 93.399; 93.351 Part 2. Full Text Announcement Section VII. Agency Contacts Scientific/Research Contact(s) Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov Financial/Grants Management Contact(s) Artisha Y. Eatmon   National Center Advancing Translational Sciences NCATS) Office Research Infrastructure Programs ORIP) Telephone: 301-435-0845 Email: artisha.eatmon@nih.gov other changes made this FOA. Inquiries Please direct inquiries to: Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov data science, big data, informatics
Notice of Participation of the Office of Research Infrastructure Programs in PA-14-154 "Early Stage Development of Technologies in Biomedical Com NOT-OD-15-161 ORIP Sep 24 2015 N/A Notice Participation the Office Research Infrastructure Programs PA-14-154 Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R43/R44)" Notice Number: NOT-OD-15-161 Key Dates Release Date:   September 24, 2015 Related Announcements PA-14-154 Issued Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Purpose purpose this Notice to inform potential applicants the Office Research Infrastructure Programs ORIP) participating, effective immediately, PA-14-154 quot;Early Stage Development Technologies Biomedical Computing, Informatics, Big Data Science R43/R44)". following sections PA-14-154 been updated reflect ORIP participation this FOA. Part 1.  Overview Information Components Participating Organizations National Institute General Medical Sciences NIGMS) National Human Genome Research Institute NHGRI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Dental Craniofacial Research NIDCR) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Cancer Institute NCI) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Catalog Federal Domestic Assistance CFDA) Number(s) 93.859; 93.273; 93.361; 97.853; 93.286; 93.865; 93.846; 93.172; 93.113; 93.242; 93.879; 93.855; 93.856; 93.279; 93.393; 93.394; 93.395; 93.396; 93.399; 93.351 Part 2. Full Text Announcement Section VII. Agency Contacts Scientific/Research Contact(s) Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov Financial/Grants Management Contact(s) Artisha Y. Eatmon   National Center Advancing Translational Sciences NCATS) Office Research Infrastructure Programs ORIP) Telephone: 301-435-0845 Email: artisha.eatmon@nih.gov other aspects this FOA remain same. Inquiries Please direct inquiries to: Miguel Contreras, Ph.D. Office Research Infrastructure Programs ORIP) Telephone: 301-594-9410 Email: contre1@mail.nih.gov data science, big data, informatics
Notice of Participation of NIGMS in RFA-MD-16-002 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science (R25)" NOT-GM-16-112 NIGMS Aug 25 2016 N/A Notice Participation NIGMS RFA-MD-16-002 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-GM-16-112 Key Dates Release Date: August 25, 2016   Related Announcements RFA-MD-16-002 Issued National Institute General Medical Sciences NIGMS) Purpose purpose this Notice to add National Institute General Medical Sciences NIGMS) RFA-MD-16-002 nbsp;"NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections of RFA-MD-16-002 have updated reflect participation NIGMS this Funding Opportunity Announcement FOA). Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Heart, Lung, Blood Institute NHLBI) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Environmental Health Sciences NIEHS) National Center Complementary Integrative Health NCCIH)  Office Research Infrastructure Programs ORIP) National Human Genome Research Institute NHGRI) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Neurological Disorders Stroke NINDS) National Library Medicine NLM) National Institute Aging NIA) National Eye Institute NEI) National Cancer Institute NCI) National Institute Drug Abuse NIDA) National Institute Alcohol Abuse Alcoholism NIAAA) National Center Advancing Translational Sciences NCATS) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Office Strategic Coordination Common Fund) Office Research Women’s Health ORWH) National Institute General Medical Sciences NIGMS) Catalog Federal Domestic Assistance CFDA) Number(s) 93.307; 93.351; 93.846; 93.213; 93.113; 93.173; 93.837, 93.838, 93.839, 93.233, 93.840; 93.855; 93.856; 93.121; 93.172; 93.847;93.853; 93.879; 93.866; 93.310; 93.307; 93.867; 93.398; 93.279; 93.273; 93.350; 93.242; 93.865; 93.859 other aspects this Funding Opportunity Announcement remain same. Inquiries Please direct inquiries to: Susan K. Gregurick, Ph.D. National Institute General Medical Sciences NIGMS) Telephone: 301-594-5135 Email: Susan.gregurick@nih.gov data science, big data
Notice of Participation of Additional NIH Institutes and Centers in RFA-MD-16-002 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomed NOT-HG-16-022 NHGRI Aug 08 2016 N/A Notice Participation Additional NIH Institutes Centers RFA-MD-16-002 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-HG-16-022 Key Dates Release Date:   August 8, 2016 Related Announcements RFA-MD-16-002     Issued National Human Genome Research Institute NHGRI) Purpose purpose this Notice to add additional NIH Institutes Centers ICs) RFA-MD-16-002 quot;NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections RFA-MD-16-002 been updated reflect participation these additional ICs this Funding Opportunity Announcement FOA): Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Environmental Health Sciences NIEHS) National Center Complementary Integrative Health NCCIH) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) National Human Genome Research Institute NHGRI) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Neurological Disorders Stroke NINDS) National Library Medicine NLM) National Institute Aging NIA) National Eye Institute NEI) National Cancer Institute NCI) National Institute Drug Abuse NIDA) National Institute Alcohol Abuse Alcoholism NIAAA) National Center Advancing Translational Sciences NCATS) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Office Strategic Coordination Common Fund) Office Research Women’s Health ORWH) Catalog Federal Domestic Assistance CFDA) Number(s) 93.307; 93.351; 93.846; 93.213; 93.113; 93.173; 93.121; 93.172; 93.847;93.853; 93.879; 93.866; 93.310; 93.307; 93.867; 93.398; 93.279; 93.273; 93.350; 93.242; 93.865 other aspects this Funding Opportunity Announcement remain same. Inquiries Please direct inquiries to: Bettie J. Graham, Ph.D. Telephone: 301-496-7531 Email: bd2k_training@mail.nih.gov data science, big data
Notice of Participation by the Fogarty International Center in RFA-ES-16-002 "BD2K Mentored Career Development Award in Biomedical Big Data Scien NOT-TW-16-003 FIC May 18 2016 N/A Notice Participation the Fogarty International Center RFA-ES-16-002 BD2K Mentored Career Development Award Biomedical Big Data Science Clinicians Doctorally Prepared Scientists K01)" Notice Number: NOT-TW-16-003 Key Dates Release Date:   May 18, 2016 Related Announcements RFA-ES-16-002 Issued Fogarty International Center FIC) Purpose purpose this Notice to inform potential applicants the Fogarty International Center FIC) participate, effective immediately, RFA-ES-16-002, BD2K Mentored Career Development Award Biomedical Big Data Science Clinicians Doctorally Prepared Scientists K01)". following changes been to reflect FIC's participation this FOA. Part I. Overview Information Components Participating Organizations National Institute Environmental Health Sciences NIEHS) National Cancer Institute NCI) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Mental Health NIMH) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) Fogarty International Center FIC) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives, Office Disease Prevention ODP) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Office Behavioral Social Sciences Research OBSSR) Office Research Women’s Health ORWH) Office Strategic Coordination Common Fund) Catalog Federal Domestic Assistance CFDA) Number(s): 93.113; 93.398; 93.867; 93.233; 93.837; 93.839; 93.838; 93.840; 93.172; 93.866; 93.273; 93.856; 93.846; 93.286; 93.865; 93.173; 93.121; 93.847; 93.279; 93.307; 93.242; 93.853; 93.361; 93.879; 93.213; 93.350; 93.351; 93.313; 93.310; 93.855; 93.313; 93.989 Part 2. Section VII. Agency Contacts following FIC contacts added: Scientific/Research Contacts: Laura Povlich, Ph.D. Fogarty International Center FIC)) Telephone: 301-827-2227 Email: laura.povlich@nih.gov Financial/Grants Management Contact(s) Bruce Butrum Fogarty International Center FIC) Telephone: 301-496-1670 Email: butrumb@mail.nih.gov other aspects the FOA remain same. Inquiries Please direct inquiries to: Laura Povlich, Ph.D. Fogarty International Center FIC) Telephone: 301-827-2227 Email: laura.povlich@nih.gov data science, big data
Notice of NLM's Participation in PAR-19-093 "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Dispariti NOT-LM-19-002 NLM Dec 20 2018 N/A Notice NLM's Participation PAR-19-093 Leveraging Health Information Technology Health IT) Address Minority Health Health Disparities R01 Clinical Trial Optional)" Notice Number: NOT-LM-19-002 Key Dates Release Date: December 20, 2018 Related Announcements PAR-19-093 Issued National Library Medicine NLM) Purpose purpose this Notice to inform potential applicants the National Library Medicine NLM) participate, effective immediately, PAR-19-093, ldquo;Leveraging Health Information Technology Health IT) Address Minority Health Disparities R01 Clinical Trial Optional)" following changes updates made to PAR-19-093 (shown italics) reflect NLM’s participation this FOA.  National Library Medicine seeks applications novel biomedical informatics data science approaches can help reduce disparities increasing access care, delivery higher quality care, improving patient-clinician communication, health outcomes minority health health disparity populations the U.S. The scope NLM's interest these research domains broad, emphasis new methods approaches foster data driven discovery improve usability understandability health information. NLM also interested research approaches helping consumers acquire, manage use data their own health. Biomedical informatics data science draw upon fields, including mathematics, statistics, information science, computer science engineering, social/behavioral sciences. Application domains include health care delivery, basic biomedical research, clinical translational research, precision medicine, public health, biosurveillance, similar areas. NLM defines biomedical informatics the science optimal representation, organization, management, integration presentation information relevant human health biology. NIH defines data science the interdisciplinary field inquiry which quantitative analytical approaches, processes, systems developed used extract knowledge insights increasingly large and/or complex sets data. this Funding Opportunity Announcement, NLM support applications involving small, early-stage Phase clinical trials are part the evaluation components research projects involving biomedical informatics and/or data science. clinical trials involve safety, feasibility validation studies inform research project. NLM not support applications proposing Phase II, III IV clinical trials. Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Cancer Institute NCI) Office Behavioral Social Sciences Research OBSSR) National Institute Biomedical Imaging Bioengineering(NIBIB) National Library Medicine NLM) Catalog Federal Domestic Assistance CFDA) Number(s) 93.307, 93.399, 93.286, 93.879 Part 2. Section VII. Agency Contact(s) Scientific/Research Contact(s) Alan VanBiervliet, Ph.D. National Library Medicine NLM) Telephone: 301-594-1297 Email: vanbiervlietag@mail.nih.gov Financial/Grants Management Contact(s) Samantha Tempchin National Library Medicine NLM) Telephone: 301-496-4221 Email: tempchins@mail.nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Alan VanBiervliet, Ph.D. NLM/Extramural Programs Telephone: 301-594-1297 Email: vanbiervlietag@mail.nih.gov data science, informatics, statistics
Notice of NLM Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career NOT-LM-20-002 NLM Dec 19 2019 N/A Notice NLM Participation PAR-19-343 Maximizing Opportunities Scientific Academic Independent Careers MOSAIC) Postdoctoral Career Transition Award Promote Diversity K99/R00 - Independent Clinical Trial Allowed)" Notice Number: NOT-LM-20-002 Key Dates Release Date: December 19, 2019 Related Announcements PAR-19-343 Issued National Library Medicine NLM) Purpose purpose this Notice to inform potential applicants the National Library Medicine NLM) participate, effective immediately, PAR-19-343 Maximizing Opportunities Scientific Academic Independent Careers MOSAIC) Postdoctoral Career Transition Award Promote Diversity K99/R00 - Independent Clinical Trial Allowed)." following changes updates made PAR-19-343 shown italics) reflect NLM’s participation this FOA. Part 1. Overview Information Components Participating Organizations National Institute General Medical Sciences NIGMS) National Institute Biomedical Imaging Bioengineering ( NIBIB ) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Human Genome Research Institute ( NHGRI ) National Institute Aging NIA) National Library Medicine NLM) Catalog Federal Domestic Assistance CFDA) Number(s) 93.859, 93.286, 93.361, 93.307, 93.172, 93.866, 93.879 Part 2. Section I. Funding Opportunity Description Program Considerations NLM participates NIH-wide programs increase diversity the research workforce. goal this FOA to help outstanding postdoctoral researchers are considered under-represented minority science transition independent, tenure-track equivalent faculty positions. NLM supports research career development clinical/public health informatics, translational bioinformatics, data science consumer informatics. define informatics the intersection computer, information behavioral sciences one more application domains. Application domains interest include health care delivery, basic biomedical research, clinical translational research, public health others. Whatever application domain, research career focus must informatics data science. Section II. Award Information Award Budget Information Salary Support: NLM contribute to 50,000 per year plus fringe benefits toward salary the career award recipient the K99 phase. Research Support: NLM provide to 20,000 per year the K99 phase. Program-Related Expenses TRAVEL: application request to 2,500 annually defray cost participation professional meetings excluding MOSAIC associated meetings, costs which be covered the UE5 awardees). Part 2. Section VII. Agency Contact(s) Scientific/Research Contact(s) Hua-Chuan Sim, MD National Library Medicine NLM) Telephone: 301-594-4882 Email: simh@mail.nih.gov Peer Review Contact(s) Zoe Huang, MD National Library Medicine NLM) Telephone: 301-496-4253 Email: huangz@mail.nlm.nih.gov Financial/Grants Management Contact(s) Samantha Tempchin National Library Medicine NLM) Telephone: 301-496-4221 Email: tempchins@mail.nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Hua-Chuan Sim, MD National Library Medicine NLM) Telephone: 301-594-4882 Email: simh@mail.nih.gov

Pages

XLS